Who we are?
IngreDiZymes is a biotechnology spin‑off bridging scientific expertise, specializing in bioactive peptides and phytochemicals derived from natural sources.
Our ingredients target areas include human functional nutrition and nutraceuticals, animal and pet functional products or cosmetic products.
From A to Z, with Zero Limits — full-cycle development for your goals | From A to Z, with Zero Limits — full-cycle development for your goals | From A to Z, with Zero Limits — full-cycle development for your goals |From A to Z, with Zero Limits — full-cycle development for your goals | From A to Z, with Zero Limits — full-cycle development for your goals | From A to Z, with Zero Limits — full-cycle development for your goals |
Our origin?
IngreDiZymes was founded as a biotechnology-based spin-off from the Universitat Rovira i Virgili (URV) emerging from the pioneering work of Nutrigenomics Research Group, built on years of scientific expertise in enzymatic biotransformation, bioactive discovery and molecular nutrition, the company focuses on developing innovative bioactive ingredients and advanced functional solutions.
Our mission is to translate cutting-edge academic research into high-impact applications that improve nutrition, health and well-being across multiple sectors.
Understanding of our Brand
The letters I, D, and Z stand for Innovation, Development, and Zero limits — the three pillars that define our scientific identity. Together, they express our mission to transforming advanced research into real biotechnological solutions that improve health and industry performance. We take innovation and development all the way to Z — and then beyond.
I, D, Z — The Infinite Zone of Innovation and Development.
Where research expands to infinity and enzymatic science becomes boundless.
Mission
Provide science‑based functional solutions in development of bioactive ingredients.
Vision
Science that translates: we bring precision, innovation and rigorous validation to every project from discovery to market impact.
Focus
Enzyme‑based ingredients and evidence generation through strong validation across in vitro, preclinical, and human intervention studies.
